Aspira Pathlab & Diagnostics Ltd.
BSE: 540788 | Sector: Health care |
NSE: N.A. | ISIN Code: INE500C01017 |
BSE 00:00 | 18 Jan | 26.75 |
0 (0.00%) |
OPEN
26.75 |
HIGH
26.75 |
LOW
26.75 |
NSE 05:30 | 01 Jan | Aspira Pathlab & Diagnostics Ltd |
OPEN | 26.75 |
PREVIOUS CLOSE | 26.75 |
VOLUME | 200 |
52-Week high | 38.30 |
52-Week low | 20.00 |
P/E | |
Mkt Cap.(Rs cr) | 25 |
Buy Price | 26.75 |
Buy Qty | 4800.00 |
Sell Price | 24.30 |
Sell Qty | 10.00 |
Aspira Pathlab & Diagnostics Ltd. (ASPIRAPATHLAB) - Net Profit
Net Profit
COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Profit (Rs crore) |
Sun Pharma.Inds. | 586.55 | 11.50 | 2.00 | 3211.14 |
Dr Reddy's Labs | 5082.10 | 48.30 | 0.96 | 2937.70 |
Cipla | 837.10 | 29.05 | 3.60 | 2318.17 |
Aurobindo Pharma | 998.00 | 74.35 | 8.05 | 1872.74 |
Cadila Health. | 466.85 | 6.55 | 1.42 | 1412.90 |
Divi's Lab. | 3570.80 | 26.40 | 0.74 | 1372.71 |
Glenmark Pharma. | 491.30 | -4.00 | -0.81 | 1354.55 |
Alkem Lab | 3110.05 | 76.25 | 2.51 | 1264.42 |
Alembic Pharma | 960.50 | 19.85 | 2.11 | 969.40 |
Torrent Pharma. | 2635.90 | -55.35 | -2.06 | 938.51 |
Gland Pharma | 2249.35 | -33.55 | -1.47 | 772.86 |
Lupin | 1081.85 | 2.30 | 0.21 | 727.55 |
Ipca Labs. | 1980.90 | -65.05 | -3.18 | 652.46 |
Abbott India | 14535.90 | 121.45 | 0.84 | 592.93 |
Fortis Health. | 172.30 | 6.70 | 4.05 | 513.33 |
Pfizer | 4722.00 | -91.15 | -1.89 | 509.13 |
Natco Pharma | 894.05 | -11.10 | -1.23 | 474.50 |
Apollo Hospitals | 2687.15 | 87.35 | 3.36 | 470.30 |
Granules India | 348.65 | 11.85 | 3.52 | 444.07 |
Ajanta Pharma | 1748.05 | 26.70 | 1.55 | 441.13 |
Quick Links for Aspira Pathlab & Diagnostics:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices